Progyny Inc

PGNY

NASDAQ. Currency in USD

31.95 -2.26 ( -6.22% )

Real time prices: December 06

Market Cap.
2.97B
Beta (5Y monthly)
1.65
Price/Earnings
81.86
EPS (TTM)
0.42
Forward Dividend
0.00 (0.00%)
Ex-Dividend Date
Volume
1.37M
1y Target Est.
55.57
Day's Range
32.44
-
34.51
52 Week's Range
25.67
-
53.15

Historical Summary

Performance
EPS growth
Share Buybacks

About Progyny Inc

Sector
Healthcare
Industry
Health Information Services
Website
https://www.progyny.com
Exchange
NASDAQ (XNAS)
Shares Outstanding
90.43M
Employees
311
Address
1359 Broadway, New York, NY, United States, 10018
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Latest news

ELV vs. PGNY: Which Stock Should Value Investors Buy Now?
ELV vs. PGNY: Which Stock Should Value Investors Buy Now?

ELV vs. PGNY: Which Stock Is the Better Value Option?
By Zacks Investment Research - 1 week ago

Progyny Raises 2022 Financial Guidance
Progyny Raises 2022 Financial Guidance

Shipments of Key Fertility Medication Have Resumed Shipments of Key Fertility Medication Have Resumed
By GlobeNewswire Inc. - 1 week ago

ELV or PGNY: Which Is the Better Value Stock Right Now?
ELV or PGNY: Which Is the Better Value Stock Right Now?

ELV vs. PGNY: Which Stock Is the Better Value Option?
By Zacks Investment Research - 3 weeks ago

Wall Street Analysts See a 64% Upside in Progyny (PGNY): Can the Stock Really Move This High?
Wall Street Analysts See a 64% Upside in Progyny (PGNY): Can the Stock Really Move This High?

The consensus price target hints at a 63.5% upside potential for Progyny (PGNY). While empirical...
By Zacks Investment Research - 4 weeks ago

Progyny, Inc. to Present at Credit Suisse 31st Annual Healthcare Conference
Progyny, Inc. to Present at Credit Suisse 31st Annual Healthcare Conference

NEW YORK, Nov. 04, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits...
By GlobeNewswire Inc. - 4 weeks ago

2 Unstoppable Growth Stocks to Buy in 2022 and Beyond
2 Unstoppable Growth Stocks to Buy in 2022 and Beyond

These healthcare businesses not only bring intriguing growth prospects but are already profitable.
By The Motley Fool - 5 weeks ago

ELV or PGNY: Which Is the Better Value Stock Right Now?
ELV or PGNY: Which Is the Better Value Stock Right Now?

ELV vs. PGNY: Which Stock Is the Better Value Option?
By Zacks Investment Research - 6 weeks ago

Progyny, Inc. Announces Details for Its Third Quarter 2022 Results Report
Progyny, Inc. Announces Details for Its Third Quarter 2022 Results Report

NEW YORK, Oct. 18, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits...
By GlobeNewswire Inc. - 7 weeks ago